Objective. To characterize prognostic parameters for systemic lupus erythematosus (SLE) flares.
Systemic lupus erythematosus (SLE ) is a multifactorial
parameters measured at the start of the study were then correlated with the number of subsequent flares and, as autoimmune disease with an incidence of 7:100 000 [1] . The course of SLE is variable and characterized by an additional assessment, with the SLEDAI score after 1 and 2 yr. For this purpose we evaluated 120 SLE recurrent disease exacerbations. For the laboratory follow-up of inflammatory activity, parameters such as patients attending our out-patients clinic over 2 yr for signs of clinical and laboratory disease activity and anti-double-stranded DNA (dsDNA) antibodies, complement fixation and leucocytopenia have been described evaluated the SLEDAI every 3 months. [2, 3] . Although the course of SLE is characterized by recurrent flares, the term 'flare' has not been defined Patients and methods clearly. Most studies characterizing prognostic markers in SLE have therefore used survival or disability as Patients parameters of outcome. Severe organ involvement, such One hundred and twenty German Caucasian SLE as renal and neuropsychiatric lupus, have been identified patients attending the out-patients clinic who fulfilled at as risk factors [4] [5] [6] . In the few studies on exacerbations least four of the American College of Rheumatology in SLE, rather subjective definitions for flares, such as criteria for the classification of SLE [12, 13] were the physician's decision to augment immunosuppressive included in the study after informed consent. The charactherapy, were used, or exacerbations of renal involveteristics of the patients are summarized in Table 1 . One ment only were evaluated [4, [7] [8] [9] [10] . hundred and six of the patients were female and 14 were The SLE disease activity index (SLEDAI ) has been male. The average age of the patients was 45.2 yr (range shown to be reliable and reproducible [11] . The SLEDAI 18-69 yr). The diagnosis of SLE had been established increases by an average of 3 points in a flare [9] . In in the patients 6 months to 25 yr (median 9 yr) before order to establish predictors for flares, we defined the they were included in the study. term as an increase in SLEDAI of at least 3 points
The patients were seen every 3 months, and in some compared with the previous visit. Several laboratory cases additionally at the time of disease exacerbation, for 2 yr by the same doctor, who also evaluated the A correlation analysis of the frequency of flares in the bodies (ANA) (Hep2-immunofluorescence); CH50; C4 first year with marker values at the start of the study (nephelometry, Behring, Marburg, Germany); erythrorevealed an association with the ANA titre (P = 0.023), cyte sedimentation rate ( ESR); IgG (nephelometry, ESR (P = 0.001), anaemia (P = 0.006) and lymphoBehring); and SLEDAI. penia (P = 0.005), but not with antibodies against dsDNA or complement fixation titre ( Table 3 ). The Statistical correlations incidences of flares in the patients younger or older than Non-parametric tests were used because SLEDAI clearly the average age of 45.2 yr were not significantly different deviated from a Gaussian distribution. Correlations of (data not shown). SLEDAI and the 10 laboratory markers shown in Risk factors for increased SLEDAI after 1 and 2 yr Table 1 with the SLEDAI at the start of the study and 1 and 2 yr later and with the number of flares in the The SLEDAI at the start of the study correlated positnext year were determined with Spearman's test.
ively with ANA, anti-dsDNA antibodies, lymphocytoProbabilities of association of less than 0.05 were penia, and negatively with complement component C4 regarded as statistically significant. and CH50 ( Table 4) . After 1 and 2 yr, the average SLEDAI was 5.2 and 4.3 points, respectively. Correlation analysis of the laborResults atory parameters present at the onset of the study with SLEDAI after 1 and 2 yr revealed that a high SLEDAI Patients' characteristics after 1 yr was associated with ANA, lymphopenia, anaeOne hundred and twenty SLE patients were evaluated mia, dsDNA antibodies and SLEDAI at the start of the every 3 months for 2 yr. The clinical characteristics of study ( Table 4 ). The SLEDAI after 2 yr was correlated these patients visiting the out-patient clinic are summaronly with antibodies against dsDNA and SLEDAI itself ized in Table 1 . At the start of the study all patients ( Table 4) . were in clinical remission. The average SLEDAI at the start was 5.8 and the average ESR in the first hour was 22.8 mm (data not shown). 
Incidence of flares
Marker P
In the first year of the study, flares were observed in 65.5% of the patients. These markers can be measured routinely as prognostic parameters in SLE to characterize patients who are at risk and who should be followed more closely.
Discussion
Although SLE is characterized by recurrent exacerba- with a lower increase in the SLEDAI will be missed, the parameters tested has to be viewed cautiously. subsequently. Therefore, only lymphocytopenia, anae-
